Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Barry Uretsky

Concepts (614)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
97
2024
329
20.770
Why?
Coronary Occlusion
58
2023
80
11.960
Why?
Coronary Artery Disease
41
2024
324
11.570
Why?
Fractional Flow Reserve, Myocardial
39
2023
127
10.770
Why?
Angioplasty, Balloon, Coronary
48
2020
168
9.760
Why?
Stents
50
2023
376
7.700
Why?
Coronary Angiography
96
2023
369
7.460
Why?
Coronary Vessels
33
2026
170
7.030
Why?
Coronary Stenosis
22
2021
99
5.830
Why?
Myocardial Infarction
46
2024
445
4.610
Why?
Drug-Eluting Stents
22
2023
101
4.570
Why?
Treatment Outcome
120
2024
5597
4.270
Why?
Cardiac Catheterization
19
2023
229
3.610
Why?
Coronary Artery Bypass
17
2022
134
2.700
Why?
Acute Coronary Syndrome
8
2022
107
2.610
Why?
Humans
229
2026
53246
2.460
Why?
Chronic Disease
52
2023
581
2.220
Why?
Tomography, Optical Coherence
8
2018
114
2.130
Why?
Saphenous Vein
12
2021
63
1.990
Why?
Graft Occlusion, Vascular
13
2021
81
1.950
Why?
Risk Factors
65
2023
4018
1.890
Why?
Platelet Aggregation Inhibitors
11
2014
213
1.880
Why?
Myocardial Ischemia
12
2026
129
1.850
Why?
Coronary Thrombosis
8
2020
22
1.790
Why?
Registries
32
2023
652
1.610
Why?
Male
120
2024
27444
1.590
Why?
Thrombosis
11
2018
250
1.590
Why?
Predictive Value of Tests
23
2023
933
1.570
Why?
Cardiology
13
2019
106
1.560
Why?
Coronary Restenosis
8
2021
39
1.550
Why?
Myocardium
17
2013
471
1.480
Why?
Heptanoic Acids
15
2008
35
1.420
Why?
Aged
70
2023
10430
1.410
Why?
Pyrroles
15
2008
74
1.380
Why?
Time Factors
39
2023
2992
1.370
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
13
2022
146
1.320
Why?
Heart Injuries
3
2019
16
1.250
Why?
Middle Aged
78
2024
13422
1.250
Why?
Risk Assessment
26
2023
1368
1.240
Why?
Myocardial Reperfusion Injury
10
2011
53
1.130
Why?
Cardiac Tamponade
2
2024
27
1.080
Why?
Collateral Circulation
10
2020
39
1.050
Why?
Female
80
2024
28792
1.040
Why?
Vasodilator Agents
5
2016
90
0.970
Why?
Coronary Circulation
9
2024
57
0.950
Why?
Heart Failure
13
2019
531
0.940
Why?
Heart-Assist Devices
3
2020
157
0.930
Why?
Contrast Media
8
2018
178
0.900
Why?
Prosthesis Design
11
2021
266
0.880
Why?
Cardiac Catheters
4
2020
12
0.880
Why?
Ventricular Dysfunction, Left
7
2018
107
0.880
Why?
Societies, Medical
9
2019
207
0.880
Why?
Thrombolytic Therapy
2
2020
114
0.880
Why?
Pericarditis
2
2022
20
0.840
Why?
Balloon Occlusion
1
2024
17
0.810
Why?
Ventricular Function, Left
11
2023
178
0.810
Why?
Adenosine
7
2018
72
0.810
Why?
Pericardial Effusion
1
2024
40
0.800
Why?
Coronary Disease
6
2015
144
0.790
Why?
Hemorrhage
4
2019
226
0.780
Why?
Cardiovascular Agents
5
2009
66
0.760
Why?
Occupational Health
1
2023
64
0.750
Why?
Aneurysm, False
5
2020
44
0.750
Why?
Postoperative Complications
10
2019
1099
0.750
Why?
Pericarditis, Constrictive
1
2022
2
0.740
Why?
Aorta
3
2019
172
0.710
Why?
Hypotension, Controlled
1
2021
3
0.700
Why?
Radiography, Interventional
7
2018
58
0.700
Why?
Anemia
1
2022
76
0.680
Why?
Retrospective Studies
27
2020
6821
0.680
Why?
Thrombocytopenia
1
2022
89
0.670
Why?
Mammary Arteries
3
2017
10
0.670
Why?
Absorbable Implants
2
2022
13
0.660
Why?
Inferior Wall Myocardial Infarction
1
2020
1
0.640
Why?
Thiazolidinediones
6
2008
81
0.640
Why?
Time-to-Treatment
2
2020
81
0.620
Why?
Prognosis
16
2023
2118
0.620
Why?
Algorithms
4
2021
668
0.620
Why?
Shock, Cardiogenic
1
2020
35
0.620
Why?
Cardiovascular Diseases
11
2015
501
0.610
Why?
Digitalis
1
2019
4
0.600
Why?
Diabetic Angiopathies
2
2013
23
0.600
Why?
Enbucrilate
1
2019
6
0.600
Why?
Tissue Adhesives
1
2019
15
0.600
Why?
Arterial Pressure
1
2019
44
0.590
Why?
Hyperemia
3
2016
17
0.590
Why?
Pericardium
4
2022
31
0.590
Why?
Operative Time
3
2019
78
0.580
Why?
Guideline Adherence
1
2020
143
0.580
Why?
Practice Guidelines as Topic
2
2020
502
0.560
Why?
Aspirin
5
2022
123
0.550
Why?
Hematoma
2
2013
67
0.550
Why?
Follow-Up Studies
16
2019
2318
0.530
Why?
Hydrostatic Pressure
1
2017
7
0.530
Why?
Myocardial Bridging
2
2026
3
0.520
Why?
Angioplasty, Balloon
4
2022
69
0.520
Why?
Death, Sudden, Cardiac
2
2008
55
0.510
Why?
Perioperative Care
5
2015
44
0.510
Why?
Heart Septum
2
2010
21
0.510
Why?
Creatine Kinase, MB Form
3
2013
10
0.510
Why?
Adrenergic beta-Antagonists
3
2008
108
0.510
Why?
Surgical Procedures, Operative
4
2015
66
0.500
Why?
Foramen Ovale, Patent
2
2014
32
0.490
Why?
Purinergic P2Y Receptor Antagonists
2
2014
35
0.480
Why?
Heart Ventricles
4
2012
260
0.480
Why?
Veterans
1
2022
580
0.470
Why?
United States
25
2022
5413
0.460
Why?
Electrocardiography
10
2022
272
0.460
Why?
Propranolol
2
2008
77
0.460
Why?
Prospective Studies
14
2023
2412
0.460
Why?
Severity of Illness Index
13
2019
1049
0.460
Why?
Alloys
2
2020
10
0.450
Why?
Fibrinolytic Agents
3
2014
132
0.440
Why?
Aortic Valve
3
2022
130
0.440
Why?
Tomography, X-Ray Computed
5
2013
1183
0.430
Why?
Wounds, Penetrating
1
2015
39
0.430
Why?
Vascular System Injuries
1
2015
42
0.430
Why?
Randomized Controlled Trials as Topic
10
2015
630
0.420
Why?
Ultrasonography, Interventional
7
2013
138
0.420
Why?
Purines
2
2014
33
0.420
Why?
Cardiotonic Agents
7
2019
70
0.420
Why?
Adenosine A2 Receptor Agonists
1
2014
5
0.410
Why?
Stroke Volume
7
2023
150
0.410
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2009
46
0.410
Why?
Physician-Patient Relations
1
2015
146
0.400
Why?
Anterior Wall Myocardial Infarction
2
2012
7
0.400
Why?
Computer-Assisted Instruction
1
2014
30
0.400
Why?
Metals
2
2011
37
0.400
Why?
Cyclooxygenase 2
8
2008
49
0.400
Why?
Piperazines
2
2012
125
0.400
Why?
Anticholesteremic Agents
3
2008
31
0.390
Why?
Troponin T
2
2011
13
0.390
Why?
Pyrazoles
2
2014
123
0.390
Why?
Blood Vessel Prosthesis Implantation
4
2009
135
0.390
Why?
Arteries
1
2013
93
0.390
Why?
Mentors
1
2014
57
0.390
Why?
Atrial Function, Left
1
2013
5
0.390
Why?
Incidence
12
2018
1085
0.380
Why?
Endarterectomy, Carotid
2
2011
63
0.380
Why?
Lipoxins
3
2008
3
0.380
Why?
Cardiac Surgical Procedures
3
2014
331
0.370
Why?
Rats, Sprague-Dawley
14
2008
1544
0.370
Why?
Rats
19
2011
3164
0.370
Why?
Tissue Donors
1
2013
130
0.370
Why?
Physicians
2
2015
242
0.370
Why?
Drug Eruptions
1
2012
14
0.370
Why?
Thiophenes
1
2012
45
0.360
Why?
Stroke
3
2013
520
0.360
Why?
Drug Administration Schedule
5
2014
370
0.360
Why?
Quality Assurance, Health Care
4
2012
146
0.350
Why?
Embolism
2
2013
18
0.350
Why?
Cyclooxygenase Inhibitors
5
2007
40
0.350
Why?
Angina Pectoris
3
2026
20
0.350
Why?
Internet
1
2014
265
0.340
Why?
Diverticulum
1
2011
21
0.340
Why?
Troponin I
1
2011
19
0.340
Why?
Intraoperative Complications
4
2020
114
0.340
Why?
Transurethral Resection of Prostate
1
2011
10
0.330
Why?
Carotid Arteries
1
2011
77
0.330
Why?
Clinical Trials as Topic
4
2012
466
0.330
Why?
Pressure
3
2017
102
0.330
Why?
Receptors, Adrenergic, beta-2
2
2009
16
0.330
Why?
Myocytes, Cardiac
5
2011
147
0.330
Why?
Embolic Protection Devices
1
2010
7
0.330
Why?
Clinical Competence
4
2013
406
0.330
Why?
Receptors, Opioid, delta
2
2009
25
0.330
Why?
Paclitaxel
1
2011
91
0.320
Why?
Heart
5
2006
350
0.320
Why?
Pericardiectomy
2
2024
6
0.320
Why?
Mitral Valve
1
2010
57
0.310
Why?
Endocarditis
1
2010
31
0.310
Why?
Kaplan-Meier Estimate
6
2017
487
0.310
Why?
Digoxin
3
2019
21
0.310
Why?
Sirolimus
2
2009
72
0.290
Why?
Echocardiography, Transesophageal
2
2006
63
0.290
Why?
Anticoagulants
5
2024
280
0.290
Why?
Carotid Artery, Common
2
2006
45
0.280
Why?
Tissue Plasminogen Activator
1
2009
108
0.280
Why?
Hypoglycemic Agents
3
2006
227
0.280
Why?
Heart Failure, Systolic
1
2008
7
0.280
Why?
Suction
1
2008
22
0.270
Why?
Peptides
2
2008
234
0.270
Why?
Azetidines
1
2008
7
0.270
Why?
Heart Valve Prosthesis
2
2022
89
0.270
Why?
Aortic Valve Stenosis
2
2022
79
0.270
Why?
Consensus
2
2007
206
0.270
Why?
Patient Selection
7
2012
273
0.270
Why?
Animals
26
2026
13528
0.270
Why?
Heart Septal Defects, Atrial
2
2013
45
0.260
Why?
Telemedicine
1
2014
512
0.260
Why?
Vascular Patency
5
2020
88
0.250
Why?
Hemodynamics
7
2018
236
0.250
Why?
Laboratories, Hospital
1
2006
6
0.250
Why?
Defibrillators, Implantable
2
2007
62
0.250
Why?
Coronary Aneurysm
1
2007
18
0.250
Why?
Terminology as Topic
3
2013
72
0.240
Why?
Chi-Square Distribution
3
2017
291
0.240
Why?
Echocardiography, Three-Dimensional
1
2006
15
0.240
Why?
Pacemaker, Artificial
1
2007
42
0.240
Why?
Mitral Valve Insufficiency
2
2007
56
0.240
Why?
Angina, Unstable
3
2016
25
0.230
Why?
Bacteremia
1
2007
87
0.230
Why?
Inpatients
2
2018
208
0.230
Why?
Gadolinium DTPA
1
2005
26
0.230
Why?
Kidney Failure, Chronic
2
2004
210
0.220
Why?
Lipopolysaccharides
1
2006
203
0.220
Why?
Nitric Oxide Synthase Type III
6
2008
83
0.220
Why?
Calcium
1
2007
373
0.220
Why?
Carotid Artery Diseases
1
2005
33
0.220
Why?
Proportional Hazards Models
6
2017
445
0.220
Why?
Angina, Stable
2
2016
7
0.220
Why?
Prostaglandins
1
2005
21
0.220
Why?
Neovascularization, Physiologic
2
2005
86
0.220
Why?
Program Evaluation
1
2006
359
0.220
Why?
Renal Insufficiency
1
2005
108
0.220
Why?
Pain Management
3
2015
185
0.210
Why?
Chemokine CCL2
1
2004
66
0.210
Why?
Plasminogen Activator Inhibitor 1
1
2004
7
0.210
Why?
Europe
6
2019
91
0.210
Why?
History, 21st Century
2
2019
60
0.210
Why?
Pericardiocentesis
1
2024
16
0.210
Why?
Monocytes
1
2004
126
0.210
Why?
Equipment Design
3
2020
290
0.200
Why?
History, 20th Century
2
2019
97
0.200
Why?
Staphylococcal Infections
1
2007
271
0.200
Why?
Reoperation
5
2013
476
0.200
Why?
Reproducibility of Results
6
2016
1221
0.200
Why?
Secondary Prevention
2
2015
85
0.200
Why?
Heart Rupture, Post-Infarction
1
2003
3
0.200
Why?
Cardiomyopathy, Hypertrophic
1
2004
34
0.200
Why?
Disease Models, Animal
9
2011
1517
0.190
Why?
Nitric Oxide Synthase Type II
4
2008
64
0.190
Why?
Double-Blind Method
5
2020
729
0.190
Why?
Adult
14
2019
14541
0.190
Why?
Dose-Response Relationship, Drug
8
2017
1367
0.190
Why?
Materials Testing
2
2020
55
0.190
Why?
Calcinosis
1
2023
53
0.190
Why?
American Heart Association
4
2015
44
0.180
Why?
Hospital Mortality
5
2019
457
0.180
Why?
Femoral Artery
2
2019
106
0.180
Why?
Coronary Vessel Anomalies
2
2017
37
0.180
Why?
Recurrence
7
2016
694
0.180
Why?
Angiography
3
2012
114
0.170
Why?
Retreatment
2
2012
60
0.170
Why?
Drug Therapy, Combination
5
2008
405
0.170
Why?
Vasodilation
1
2021
100
0.160
Why?
Up-Regulation
4
2011
456
0.160
Why?
Heart Valve Prosthesis Implantation
2
2016
103
0.160
Why?
United States Department of Veterans Affairs
1
2022
295
0.160
Why?
Ischemia
1
2021
158
0.160
Why?
Angioplasty
1
2020
21
0.150
Why?
Calcitonin Gene-Related Peptide
2
2009
23
0.150
Why?
Risk
3
2011
306
0.150
Why?
6-Ketoprostaglandin F1 alpha
3
2008
4
0.150
Why?
Plaque, Atherosclerotic
1
2019
45
0.150
Why?
Logistic Models
3
2018
947
0.150
Why?
Specialization
1
2019
48
0.150
Why?
Cost-Benefit Analysis
2
2014
274
0.140
Why?
Atherectomy
1
2019
14
0.140
Why?
Russia
4
2019
10
0.140
Why?
Quality Improvement
2
2011
230
0.140
Why?
Propanolamines
2
2011
13
0.140
Why?
Radial Artery
1
2019
34
0.140
Why?
Catheterization
1
2019
95
0.140
Why?
Survival Analysis
5
2010
659
0.140
Why?
Odds Ratio
3
2016
567
0.140
Why?
Peripheral Arterial Disease
1
2019
84
0.140
Why?
Catheterization, Peripheral
1
2019
49
0.140
Why?
Proto-Oncogene Proteins c-akt
3
2009
171
0.140
Why?
Patient Care Planning
1
2019
69
0.140
Why?
Feasibility Studies
1
2020
412
0.140
Why?
Aged, 80 and over
5
2017
3495
0.140
Why?
Patient Safety
1
2018
103
0.130
Why?
Emergency Medical Services
1
2019
122
0.130
Why?
Medicare
2
2011
280
0.130
Why?
Education, Medical
1
2019
111
0.130
Why?
Diabetes Mellitus, Type 2
1
2004
591
0.130
Why?
Constriction, Pathologic
1
2017
91
0.130
Why?
Adventitia
1
2017
3
0.130
Why?
Education, Medical, Graduate
3
2013
219
0.130
Why?
Curriculum
3
2013
409
0.130
Why?
Hospitalization
3
2011
749
0.130
Why?
Cardiac Pacing, Artificial
2
2008
32
0.120
Why?
Advisory Committees
2
2014
75
0.120
Why?
Prevalence
4
2018
1034
0.120
Why?
Phosphorylation
6
2008
533
0.120
Why?
Nitric Oxide Synthase
2
2008
64
0.120
Why?
Simvastatin
2
2008
28
0.120
Why?
Propensity Score
1
2017
170
0.120
Why?
Aortic Valve Insufficiency
1
2016
25
0.120
Why?
Administration, Oral
5
2015
456
0.120
Why?
Benzazepines
2
2006
20
0.110
Why?
Magnetic Resonance Imaging
1
2022
1587
0.110
Why?
Renal Insufficiency, Chronic
1
2018
205
0.110
Why?
Postpericardiotomy Syndrome
1
2015
4
0.110
Why?
Diagnostic Techniques, Cardiovascular
2
2012
4
0.110
Why?
Colchicine
1
2015
25
0.110
Why?
Smad3 Protein
1
2014
9
0.110
Why?
Cholesterol, Dietary
1
2014
19
0.110
Why?
Th2 Cells
1
2014
20
0.110
Why?
Cyclic AMP-Dependent Protein Kinases
3
2011
50
0.110
Why?
Patient Care Management
1
2014
18
0.100
Why?
Venous Thrombosis
1
2015
91
0.100
Why?
Area Under Curve
3
2022
185
0.100
Why?
Receptors, LDL
1
2014
73
0.100
Why?
Health Care Costs
1
1995
178
0.100
Why?
Cardiovascular System
1
2014
55
0.100
Why?
Thromboembolism
1
2014
48
0.100
Why?
Atherosclerosis
2
2014
224
0.100
Why?
Transfection
1
2014
359
0.100
Why?
Dependovirus
1
2014
104
0.100
Why?
Drug Costs
1
2014
40
0.100
Why?
Remote Consultation
1
2014
30
0.100
Why?
Quality Indicators, Health Care
2
2011
92
0.100
Why?
Arrhythmias, Cardiac
2
2012
98
0.100
Why?
Cardiac Output, Low
2
2006
10
0.100
Why?
Septal Occluder Device
1
2013
36
0.100
Why?
Echocardiography, Doppler, Color
1
2013
21
0.100
Why?
Pulmonary Edema
1
2013
15
0.100
Why?
Echocardiography, Doppler
2
2016
56
0.100
Why?
Cohort Studies
5
2022
1557
0.100
Why?
General Surgery
1
2014
108
0.090
Why?
Heparin
2
2024
86
0.090
Why?
Evidence-Based Medicine
2
2011
275
0.090
Why?
Signal Transduction
3
2009
1748
0.090
Why?
Pleural Effusion
1
2013
38
0.090
Why?
Case-Control Studies
2
2013
1212
0.090
Why?
Image Processing, Computer-Assisted
1
2014
235
0.090
Why?
Kidney Diseases
2
2007
230
0.090
Why?
Multivariate Analysis
4
2016
598
0.090
Why?
Heart Transplantation
3
2009
327
0.090
Why?
Embolism, Cholesterol
1
2011
2
0.090
Why?
Age Factors
3
2021
1136
0.090
Why?
Hypertrophy, Left Ventricular
2
2009
42
0.090
Why?
Myocardial Revascularization
2
2012
29
0.090
Why?
Ultrasonography
2
2010
426
0.090
Why?
Cardiovascular Surgical Procedures
2
2012
12
0.090
Why?
Milrinone
1
2011
7
0.090
Why?
Treatment Failure
2
2018
119
0.090
Why?
Insurance Claim Review
1
2011
42
0.080
Why?
Enkephalin, D-Penicillamine (2,5)-
2
2009
3
0.080
Why?
Equipment Failure
2
2008
64
0.080
Why?
Unnecessary Procedures
1
2011
20
0.080
Why?
Punctures
2
2019
52
0.080
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2011
73
0.080
Why?
Thrombectomy
1
2011
74
0.080
Why?
Necrosis
1
2010
169
0.080
Why?
Cyclooxygenase 2 Inhibitors
2
2007
22
0.080
Why?
Injections, Intra-Arterial
2
2015
14
0.080
Why?
Cells, Cultured
4
2009
1569
0.080
Why?
Disease Management
3
2014
187
0.080
Why?
Surgical Instruments
1
2010
29
0.080
Why?
Systole
1
2010
71
0.080
Why?
Magnetic Resonance Imaging, Cine
1
2010
64
0.080
Why?
Endothelium, Vascular
3
2007
262
0.080
Why?
Receptors, Calcitonin Gene-Related Peptide
1
2009
4
0.080
Why?
Reperfusion Injury
2
2007
83
0.080
Why?
Phosphodiesterase Inhibitors
2
2007
21
0.080
Why?
Myocardial Contraction
2
2009
109
0.070
Why?
ROC Curve
2
2022
246
0.070
Why?
Hyperlipidemias
2
2011
52
0.070
Why?
Drug Administration Routes
1
2008
10
0.070
Why?
Survival Rate
3
2018
949
0.070
Why?
Leukotriene B4
1
2008
1
0.070
Why?
Fatal Outcome
2
2007
193
0.070
Why?
Arachidonate 5-Lipoxygenase
1
2008
3
0.070
Why?
Hemostasis, Surgical
1
2008
11
0.070
Why?
Phospholipases A
2
2006
14
0.070
Why?
Phospholipases A2
2
2006
15
0.070
Why?
Diabetes Complications
2
2011
124
0.070
Why?
Patient Transfer
1
2009
99
0.070
Why?
Comorbidity
1
2010
638
0.070
Why?
Meta-Analysis as Topic
1
2008
40
0.070
Why?
Drainage
1
2008
92
0.070
Why?
Sulfonamides
2
2008
139
0.070
Why?
Myocardial Reperfusion
1
2007
13
0.070
Why?
Combined Modality Therapy
1
2009
640
0.070
Why?
Mitogen-Activated Protein Kinase 3
1
2007
46
0.060
Why?
Tetrazoles
1
2007
41
0.060
Why?
Prosthesis Failure
2
2012
113
0.060
Why?
Dipyridamole
1
2007
7
0.060
Why?
Microinjections
2
2018
34
0.060
Why?
Prostaglandin D2
1
2007
21
0.060
Why?
Cyclooxygenase 1
1
2007
7
0.060
Why?
Analysis of Variance
1
2008
547
0.060
Why?
Sex Factors
2
2022
747
0.060
Why?
Waiting Lists
1
2007
56
0.060
Why?
Disease Progression
2
2008
880
0.060
Why?
Calcium Signaling
1
2007
52
0.060
Why?
Nitroso Compounds
1
2006
3
0.060
Why?
Patient Admission
1
2007
81
0.060
Why?
Thoracic Surgery
1
2007
22
0.060
Why?
Enzyme Induction
1
2006
75
0.060
Why?
PPAR gamma
1
2007
74
0.060
Why?
Biotin
1
2006
46
0.060
Why?
NF-kappa B
1
2008
327
0.060
Why?
Chest Pain
1
2006
55
0.060
Why?
Drug Interactions
1
2007
196
0.060
Why?
Ubiquinone
1
2006
14
0.060
Why?
Acute Disease
3
2019
393
0.060
Why?
Diagnosis, Differential
2
2012
1038
0.060
Why?
Hemofiltration
1
2006
8
0.060
Why?
Magnesium
1
2006
33
0.060
Why?
Forecasting
1
2007
152
0.060
Why?
Electric Countershock
1
2006
30
0.060
Why?
Preoperative Care
1
2007
173
0.060
Why?
Intracranial Embolism
1
2006
29
0.060
Why?
Radiology
1
2008
137
0.060
Why?
Heart Atria
1
2006
63
0.060
Why?
Texas
2
2006
138
0.060
Why?
Ischemic Preconditioning
1
2005
5
0.060
Why?
Aortic Rupture
1
2006
19
0.060
Why?
Triiodobenzoic Acids
1
2005
9
0.060
Why?
Partnership Practice
1
2005
1
0.060
Why?
Organizational Affiliation
1
2005
2
0.060
Why?
Myocardial Stunning
1
2005
2
0.060
Why?
Health Planning
1
2005
13
0.060
Why?
Carbazoles
1
2005
17
0.060
Why?
Pyrrolidines
1
2006
65
0.060
Why?
Foreign Bodies
1
2006
66
0.060
Why?
Metoprolol
1
2005
13
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
124
0.060
Why?
Gastrointestinal Hemorrhage
1
2006
91
0.060
Why?
Device Removal
1
2006
89
0.060
Why?
Aortic Coarctation
1
2006
32
0.060
Why?
Accidents, Traffic
1
2006
91
0.060
Why?
Arginine Vasopressin
1
2005
6
0.060
Why?
Isoxazoles
1
2005
16
0.050
Why?
Intramolecular Oxidoreductases
1
2005
11
0.050
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
25
0.050
Why?
Tetralogy of Fallot
1
2006
83
0.050
Why?
Education, Medical, Continuing
1
2005
76
0.050
Why?
Ephedrine
1
2004
21
0.050
Why?
Leadership
1
2005
106
0.050
Why?
Regional Blood Flow
1
2004
112
0.050
Why?
Hyperhomocysteinemia
1
2004
29
0.050
Why?
Membrane Proteins
1
2007
333
0.050
Why?
Polyethylene Terephthalates
1
2004
10
0.050
Why?
Brachiocephalic Trunk
1
2004
6
0.050
Why?
Abnormalities, Multiple
1
2006
166
0.050
Why?
Ventricular Remodeling
1
2004
66
0.050
Why?
Antioxidants
1
2006
264
0.050
Why?
Pregnancy Complications, Cardiovascular
1
2004
31
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
189
0.050
Why?
Creatinine
1
2004
158
0.050
Why?
Random Allocation
1
2005
284
0.050
Why?
Arteriosclerosis
1
2004
49
0.050
Why?
Hypertension
2
2011
554
0.050
Why?
Swine Diseases
1
2004
7
0.050
Why?
Potassium Channels
1
2004
32
0.050
Why?
Inflammation
2
2007
653
0.050
Why?
ATP-Binding Cassette Transporters
1
2004
35
0.050
Why?
Enoxaparin
1
2024
32
0.050
Why?
Cytochrome P-450 Enzyme System
1
2005
191
0.050
Why?
Staphylococcus aureus
1
2007
313
0.050
Why?
Atrial Fibrillation
1
2006
196
0.050
Why?
Vasoconstrictor Agents
1
2004
81
0.050
Why?
Heart Diseases
1
2006
221
0.050
Why?
Glomerular Filtration Rate
2
2018
128
0.050
Why?
Creatine Kinase
1
2003
31
0.050
Why?
Sample Size
1
2003
50
0.050
Why?
Isoenzymes
1
2003
165
0.050
Why?
Internship and Residency
1
2008
439
0.050
Why?
Retroperitoneal Space
1
2002
26
0.050
Why?
Health Policy
2
2012
165
0.050
Why?
Death
1
2022
23
0.050
Why?
C-Reactive Protein
1
2003
152
0.050
Why?
Quality of Life
1
2008
902
0.050
Why?
Immunohistochemistry
1
2005
975
0.040
Why?
Cardiomyopathies
1
2003
120
0.040
Why?
Drug Synergism
3
2007
147
0.040
Why?
Morphine Derivatives
1
2022
28
0.040
Why?
Anesthesia
1
2002
67
0.040
Why?
Renal Dialysis
1
2003
196
0.040
Why?
Mass Screening
1
2004
362
0.040
Why?
Epoprostenol
1
2001
12
0.040
Why?
Hospitals
1
2022
181
0.040
Why?
Clinical Trials, Phase II as Topic
1
2001
48
0.040
Why?
Pulmonary Wedge Pressure
1
2001
18
0.040
Why?
Benchmarking
2
2011
64
0.040
Why?
Kidney
1
2005
717
0.040
Why?
Heart Arrest
1
2002
144
0.040
Why?
Tissue Scaffolds
1
2020
40
0.040
Why?
Arkansas
2
2016
2068
0.040
Why?
Biocompatible Materials
1
2020
67
0.040
Why?
Public Policy
2
2012
39
0.040
Why?
Antihypertensive Agents
1
2001
130
0.040
Why?
Anti-Inflammatory Agents
2
2015
164
0.040
Why?
Graft Rejection
2
2009
166
0.040
Why?
Oxidative Stress
1
2004
820
0.040
Why?
Risk Adjustment
1
2019
17
0.040
Why?
Mice, Knockout
2
2014
910
0.040
Why?
Injections, Intralesional
1
2018
32
0.040
Why?
Internationality
1
2018
46
0.040
Why?
Radiation Dosage
1
2019
160
0.030
Why?
Administration, Intravenous
1
2018
73
0.030
Why?
Immunoblotting
2
2008
118
0.030
Why?
Sex Characteristics
1
1999
204
0.030
Why?
Radiation Monitoring
1
2017
7
0.030
Why?
International Cooperation
2
2007
52
0.030
Why?
Enzyme-Linked Immunosorbent Assay
2
2008
233
0.030
Why?
Interferon-alpha
1
1996
53
0.030
Why?
Mice
3
2014
5982
0.030
Why?
Italy
1
2015
27
0.030
Why?
Blood Flow Velocity
1
2015
99
0.030
Why?
Phlebography
1
2015
55
0.030
Why?
Cost Savings
1
1995
60
0.030
Why?
Tubulin Modulators
1
2015
28
0.030
Why?
Monte Carlo Method
1
1995
89
0.030
Why?
Cross-Sectional Studies
1
2020
1723
0.030
Why?
Decision Support Techniques
1
1995
73
0.030
Why?
Cause of Death
2
2007
156
0.030
Why?
Syndrome
2
2006
248
0.030
Why?
Time
1
2014
28
0.030
Why?
Journal Impact Factor
1
2014
9
0.030
Why?
Liver Transplantation
1
1996
174
0.030
Why?
Genetic Vectors
1
2014
127
0.030
Why?
Models, Cardiovascular
2
2004
22
0.030
Why?
Fibrosis
1
2014
198
0.030
Why?
Monitoring, Physiologic
1
2014
122
0.030
Why?
Apoptosis
2
2011
1139
0.020
Why?
Learning Curve
1
2013
20
0.020
Why?
Ischemic Attack, Transient
1
2013
59
0.020
Why?
Gene Expression Regulation
2
2008
1003
0.020
Why?
Cardiac Imaging Techniques
1
2012
8
0.020
Why?
Mice, Inbred C57BL
2
2008
1925
0.020
Why?
Tissue Survival
1
2012
10
0.020
Why?
Myocardial Perfusion Imaging
1
2012
17
0.020
Why?
Exercise Test
2
2002
137
0.020
Why?
Tomography, Emission-Computed, Single-Photon
1
2012
53
0.020
Why?
Phosphodiesterase 3 Inhibitors
1
2011
1
0.020
Why?
Adrenergic beta-1 Receptor Antagonists
1
2011
7
0.020
Why?
In Situ Nick-End Labeling
1
2011
54
0.020
Why?
Echocardiography
2
2005
408
0.020
Why?
Diagnostic Imaging
1
2012
176
0.020
Why?
Recovery of Function
1
2012
203
0.020
Why?
Infusions, Intravenous
1
2011
211
0.020
Why?
Critical Care
1
2012
215
0.020
Why?
Lymphocytes
1
1991
146
0.020
Why?
Program Development
1
2011
165
0.020
Why?
Data Collection
1
2011
288
0.020
Why?
Adrenergic beta-2 Receptor Antagonists
1
2009
1
0.020
Why?
Adrenergic beta-2 Receptor Agonists
1
2009
5
0.020
Why?
Transplantation, Homologous
1
2009
154
0.020
Why?
Cell Death
1
2009
171
0.020
Why?
Isoquinolines
1
2008
22
0.020
Why?
Serine
1
2008
36
0.020
Why?
Tyrphostins
1
2008
10
0.020
Why?
Janus Kinases
1
2008
7
0.020
Why?
Electrophoretic Mobility Shift Assay
1
2008
71
0.020
Why?
Selection Bias
1
2008
15
0.020
Why?
Enzyme Activation
1
2008
267
0.020
Why?
Ischemic Preconditioning, Myocardial
1
2007
4
0.020
Why?
Organ Culture Techniques
1
2007
44
0.020
Why?
Immunologic Factors
1
2008
117
0.020
Why?
Creatine Kinase, BB Form
1
2007
1
0.020
Why?
Receptors, Purinergic P1
1
2007
7
0.020
Why?
Survival
1
2007
12
0.020
Why?
Theophylline
1
2007
18
0.020
Why?
5'-Nucleotidase
1
2007
12
0.020
Why?
Nitriles
1
2007
55
0.020
Why?
Smoking
1
2011
526
0.020
Why?
Blood Coagulation
1
2007
65
0.020
Why?
Models, Chemical
1
2007
65
0.020
Why?
Premedication
1
2007
17
0.020
Why?
Butadienes
1
2007
49
0.020
Why?
Drug Combinations
1
2007
138
0.020
Why?
Coenzymes
1
2006
3
0.020
Why?
Fluid Therapy
1
2007
79
0.020
Why?
Oncogene Protein v-akt
1
2006
12
0.010
Why?
Receptors, Vasopressin
1
2006
23
0.010
Why?
Educational Measurement
1
2008
202
0.010
Why?
Alanine
1
2006
43
0.010
Why?
Phosphoric Monoester Hydrolases
1
2006
25
0.010
Why?
Amidines
1
2006
6
0.010
Why?
Benzylamines
1
2006
14
0.010
Why?
Protein Kinase Inhibitors
1
2008
234
0.010
Why?
Sulfones
1
2006
24
0.010
Why?
PTEN Phosphohydrolase
1
2006
55
0.010
Why?
Research Design
1
2008
373
0.010
Why?
Models, Animal
1
2006
233
0.010
Why?
Nitric Oxide
1
2007
233
0.010
Why?
Magnetic Resonance Angiography
1
2006
72
0.010
Why?
Heart Conduction System
1
2005
25
0.010
Why?
Body Weight
1
2007
524
0.010
Why?
Enzyme Inhibitors
1
2007
371
0.010
Why?
Safety
1
2005
78
0.010
Why?
Nitroglycerin
1
2004
6
0.010
Why?
Multicenter Studies as Topic
1
2005
114
0.010
Why?
Radiography
1
2006
476
0.010
Why?
Injections, Intravenous
1
2004
129
0.010
Why?
Aortography
1
2004
33
0.010
Why?
Sensitivity and Specificity
1
2006
869
0.010
Why?
Glyburide
1
2004
5
0.010
Why?
Anastomosis, Surgical
1
2004
69
0.010
Why?
Anesthesia, Obstetrical
1
2004
40
0.010
Why?
Health Personnel
1
2007
259
0.010
Why?
Models, Biological
1
2007
737
0.010
Why?
Ventricular Fibrillation
1
2004
19
0.010
Why?
Vascular Surgical Procedures
1
2006
171
0.010
Why?
Patient Discharge
1
2006
325
0.010
Why?
Statistics as Topic
1
2004
89
0.010
Why?
Transcription Factors
1
2007
571
0.010
Why?
Tachycardia, Ventricular
1
2004
44
0.010
Why?
Anti-Arrhythmia Agents
1
2004
79
0.010
Why?
Cesarean Section
1
2004
158
0.010
Why?
NG-Nitroarginine Methyl Ester
1
2003
11
0.010
Why?
Swine
1
2004
440
0.010
Why?
Endpoint Determination
1
2002
27
0.010
Why?
Brain
1
2006
1353
0.010
Why?
Pregnancy
1
2004
2610
0.010
Why?
Hepatitis C
1
1996
82
0.010
Why?
HLA Antigens
1
1992
55
0.010
Why?
Immunity, Cellular
1
1991
64
0.010
Why?
Uretsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description